Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Critical Care Medicine|June 23, 2017
Molecular Adsorbent Recirculating System Can Reduce Short-Term Mortality Among Patients With Acute-on-Chronic Liver Failure-A Retrospective AnalysisHans U Gerth, Michele Pohlen, Gerold Thölking, et al.Annals of Hematology|March 28, 2013
DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one centerJan-Henrik Mikesch, Mareike Kuhlmann, Angela Demant, et al.Haematologica|July 30, 2016
Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single centerMichele Pohlen, Julia Marx, Alexander Mellmann, et al.Cancer Immunology Research|February 13, 2015
Targeting interleukin-2 to the bone marrow stroma for therapy of acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantationChristoph Schliemann, Katrin L Gutbrodt, Andrea Kerkhoff, et al.Annals of Hematology|March 24, 2019
Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)Torsten Kessler, Steffen Koschmieder, Christoph Schliemann, et al.Plos One|August 31, 2016
Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk PredictionMichele Pohlen, Nils H Thoennissen, Jan Braess, et al.Plos One|January 3, 2018
Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk PredictionMichele Pohlen, Nils H Thoennissen, Jan Braess, et al.The Journal of Allergy and Clinical Immunology|March 23, 2020
CD163 expression defines specific, IRF8-dependent, immune-modulatory macrophages in the bone marrowLena Fischer-Riepe, Niklas Daber, Jonas Schulte-Schrepping, et al.Pageof 2